Modeling of platelet concentrate yield in continuous‐flow cell separation devices

Hester, Jeane P.; Ventura, Gerard J.

doi:10.1002/jca.2920040410

Cited by 6 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are several clinical consequences. First, there is a direct correlation between donor platelet count and product platelet yield, as has been previously demonstrated during the development of platelet apheresis technology [14, 15]. The advent of instrument automaticity for platelet procurement has resulted in reproducibility of the collection process and the platelet yield.…”

Section: Discussionmentioning

confidence: 91%

Economic Impact of Donor Platelet Count and Platelet Yield in Apheresis Products: Relevance for Emerging Issues in Platelet Transfusion Therapy

et al. 1999

View full text Add to dashboard Cite

Introduction: We analyzed donor platelet counts and platelet product yields in 708 consecutive platelet aphereses in our program in order to define the importance of this relationship for emerging issues in platelet transfusion therapy. Methods: Aphereses performed on the Spectra 3.6 (COBE, Lakewood. Colo.) the CS–3000 Plus (Fenwall–Baxter, Deerfield, Ill.) were analyzed. Results: Mean platelet count was 237±49×10³/mm³ (mean ± SD), and mean yield was 4.24±1.09×10¹¹ platelets. Eigthy–five (12%) procedures generated less that 3×10¹¹ platelets. Only thirty–eight (5.4%) procedures yielded ≥6×10¹¹ platelets, so that 'split products' could be obtained. Platelet yields were primarily related to the biologic contribution (baseline platelet count) of the donor. Procedure parameters selected for harvest, and the efficiency of the device also had a significant, but less important role in determining the final platelet yield. An increase in mean donor platelet count achieved with Mpl ligand therapy from 240,000 to 320,000/mm³ would reduce the cost from USD 378 to 267 for each apheresis product, since the fraction of split products would exceed 50% of apheresis procedures. Conclusion: Increasing the donor platelet count would have a significant economic impact on platelet apheresis programs, as well as important clinical consequences for the role of platelet apheresis products in future transfusion strategies.

show abstract

Section: Discussionmentioning

confidence: 91%